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Pneumocystis Carinii Pneumonia: A Rare Cause of
Granulomatous Hypercalcemia
Swati Kumar, M.D., Mahalakshmi Honasoge, M.D., Arti Bhan, M.D.,
Anita Patel, M.D., Adarsh Babu, M.D.

Abstract

Laboratory Values

•Pneumocystis Carinii Pneumonia ( PCP ) is a well-known
complication of immunosuppression.

• Hypercalcemia heralding PCP infection has been reported in
the literature.
• Elevated calcium of 10.6 mg/dl was present one month
prior to our patient’s hospitalization around the time of
onset of his symptoms.
• Of the 19 cases of hypercalcemia due to PCP infection, 5 had
hypercalcemia that preceded PCP infection by few weeks.
(1-3)
• The gold standard for diagnosis of PCP involves
identification of the organism in induced sputum or
bronchoalveolar lavage specimen.
• Measurement of serum 1,3-β-d-Glucan, which has high
sensitivity, may be used as a screening tool in the right
clinical setting such as our patient with immunosuppression
and hypercalcemia to diagnose PCP at an earlier stage.
• We believe that hypercalcemia in a patient with
immunosuppression should alert the possibility of PCP
infection.

•Few case reports have linked PCP and its ability to induce a
granulomatous response to hypercalcemia.
•PCP related hypercalcemia appears to be resistant to standard
therapy.
•We report a case of hypercalcemia that preceded PCP and
continued to worsen during the course of infection.

Case Report
• A 63y man with renal transplant for polycystic kidney disease
one year prior, presented with three week history of fatigue,
cough and chills.
• Patient was hypoxic and CT of the thorax revealed diffuse
ground glass opacities.
• He was started on empiric therapy for PCP with intravenous
methylprednisolone, clindamycin, and primaquine.
• The patient’s bronchoalveolar lavage confirmed PCP.

Laboratory Values
• Serum Calcium - 12 mg/dl (baseline 9.2mg/dl, reference range
8.6-10.4 mg/dl)
• Creatinine - 3.23 mg/dl, which rose from a baseline value of
1.6 mg /dl.
• PTH of 15 pg/ml from a baseline of 97 pg/ml (reference range
15-65pg/ml) post-transplant
• 25-hydroxyvitamin D level of 30 ng/ml (reference range >20
ng/ml )
• 1,25-dihydroxyvitamin D(1,25D) level was elevated (>156
pg/ml; reference range 20-79 pg/ml)
• 1,25 D mediated hypercalcemia – started on intravenous fluids
and high-dose steroids

Discussion

• Serum calcium levels improved transiently but subsequently
rose to a peak level of 13.5 mg/dl.
• Ketoconazole 200 mg every 8hrs was started to reduce
1,25D production.
• Serum calcium remained high despite a reduction in 1,25D
level (33 pg/ml).
• Bisphosphonates therapy was considered unsafe because of
decreased GFR. Therefore, Denosumab 30mg was
administered, which resulted in decrease in serum calcium
level to 10.3 mg/dl by day 19.
• Overall, improvement of hypercalcemia correlated with
improvement of PCP and renal function.
• Patient was discharged home after completing the 21 day
course of treatment for PCP.
• Five weeks later, serum calcium stayed normal with an
elevated PTH of 153 pg/ml and 1,25D level of 20 pg/ml.
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